Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial

Published 2017 View Full Article

Authors

Keywords

Eczema, Paediatric, Atopic dermatitis, Anti-IgE, Omalizumab, Randomised controlled trial, Double blind, Placebo, Xolair®

Journal

Trials

Volume 18, Issue 1, Pages -

Publisher

Springer Nature

Online

2017-03-22

DOI

10.1186/s13063-017-1809-7

References

View 6 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started